DD
Invalid date
Drug Development course is an Informative and Innovative and Help full for Development of the drug after Discovering it, and Kind Request to provide the Intermediate level and Advanced level courses.
PR
Invalid date
Fantastic course, learned a lot of new things. Will go for the drug discovery course next. Consider including the presentations before the tests rather than afterwards
By Santapan S
•Jul 5, 2023
The course is pretty outdated. Also, it would be really helpful if it focused on global pharma market as well.
By Krithika S K N
•Sep 2, 2019
Was informative. The lectures could have been more structured and slides more detailed.
By Adrija C
•Nov 2, 2020
US- centric course. The content in week 3 was not well explained and felt rushed.
By Aneesh T G
•Aug 22, 2020
More emphasis on the filing and submissions and approvals need to be there
By Carolina S V
•Dec 27, 2017
Weeks 1 and 2 are great, but the classes of week 3 need more organization.
By Damien V
•Sep 17, 2018
good up to phase 2 (included). Phase 3 and after was less informative
By Sean K
•Feb 21, 2022
Lot of outdated information and poor presentation slides
By Brian M
•Apr 25, 2021
It's from 2013. Good overview but time for an update.
By Miguel M V
•Aug 30, 2020
would like an specialization on this matter
By Budupula K
•Jun 19, 2021
I gained knowledge
By Sofia B J
•Sep 2, 2020
goooooood
By Aman b
•Sep 14, 2021
good
By DR. A G
•Sep 5, 2020
good
By Pratiksha
•Jun 1, 2020
n
i
c
e
By Dale G Y
•Aug 24, 2021
Had hoped to hear a better description of the types of trials and more about the Regulators' logic in deciding what trials a drug must have - PK for ANDA? BE for ANDA? P1 and P3 for 505B2? Does PK=P1? These topics are useful. Need to define these options and explain the reason for using them for different scenarios. That's part of what I expected from Drug Development.
The lecture style of second half was difficult. More structure, clear pronunciation, less random thoughts about unexplained topics.
By Mohamed T H
•Jul 18, 2020
Phase 1 was explained nicely. But phase 2 description was unclear with some diagrams with not much context and a lot of acronyms thrown around. Did not learn a lot about phase 3 either. The presentation slides were very busy like the previous course.
By Malamati V
•Oct 23, 2020
I felt like the lectures were not so organized as far as their material is concerned. I also found the overall course more "business-oriented" than actually educational.
By Nayanika P
•Jan 8, 2022
Okayish. I wouldn't recommend this. If you're really passionate about Drug Development and it's clinical aspects, try and find better courses.
By Alejandro g
•May 28, 2020
The course was not structured as an online course. the slides were quite boring and some of the speakers were not enthusiastic
By Manuel M
•Sep 14, 2022
Outdated series of classes that offer no real learning opportunities.
By Arash Y
•Mar 3, 2018
Presentation slides and sound quality is at its lowest.
By Maria B
•Mar 18, 2020
The course is not prepared for online course
By Benoit E
•Feb 21, 2019
A lot too much bla bla on the Phase iv part
By Michael M
•Sep 9, 2020
I only looked at the slides, as I wanted to confirm, what I read in some of the reviews. A standard issue on Coursera is, that material is not maintained and updated. I have worked in the pharmaceutical industry for more than 15 years now and everything is constantly evolving. The world of 2013 is not the world of 2020 and course material should e updated regularly.
By Ananya S
•Jul 13, 2020
The data shown in the lecture and even the lecture itself is dated back to 2012. Kindly upload an updated lecture with new rules, recent data, recent examples. It would be of great help.